Stents

Calcium Corner

ABSORB III and IV: Evaluating the Safety and Effectiveness of the Absorb Bioresorbable Vascular Scaffold

01/13/2015

Cath Lab Digest talks with James B. Hermiller, MD, FACC, FSCAI,
Director of Interventional Cardiology, St. Vincent Medical Group,
Indianapolis, Indiana.

Cath Lab Digest talks with James B. H...

With the Absorb BVS, by a year, there is a loss of some of the radial strength. By two years, we start to see loss of the scaffold itself, meaning the mass and structure of the device, and by three to three and a half years, the BVS is gone.

With the Absorb BVS, by a year,...

01/13/2015

Cath Lab Digest

Conference Highlights

News from the Transcatheter Cardiovascular Therapeutics (TCT) Conference

10/15/2014

September 13-16, 2014, Washington, D.C.

September 13-16, 2014, Washington, D....

Held September 13-16, 2014, in Washington, D.C. TCT is the Cardiovascular Research Foundation’s annual scientific symposium, focusing on interventional cardiovascular medicine.

Held September 13-16, 2014, in...

10/15/2014

Cath Lab Digest